Vaccines Market Size 2025-2029
The vaccines market size is forecast to increase by USD 160.22 billion at a CAGR of 23.1% between 2024 and 2029.
- The market is experiencing significant growth, driven by increased funding for research and development, leading to the launch of new vaccines. One of the most promising trends in this market is the development of nanoparticle vaccines, which offer enhanced immunogenicity and improved delivery systems. This trend is particularly evident in the development of nanoparticle vaccines, which offer enhanced efficacy and safety. However, the high cost of research, development, and manufacturing poses a significant challenge for market players. Examples include the inactivated polio vaccine (IPV) and influenza vaccine. These costs can be attributed to the complex production processes involved in vaccine creation, as well as the need for rigorous clinical trials to ensure safety and efficacy.
- However, the high cost of vaccine research, development, and manufacturing remains a significant challenge for market participants. Despite this, the market presents numerous opportunities for companies seeking to capitalize on the growing demand for vaccines, particularly in emerging economies with rising healthcare expenditures. Strategic partnerships, collaborations, and acquisitions are key strategies for companies looking to navigate the competitive landscape and stay ahead of the curve.
- Overall, the market is poised for continued growth, with significant opportunities for innovation and investment in the coming years. Companies that can effectively address the challenges of cost and regulatory compliance while delivering high-quality, effective vaccines will be well-positioned to succeed.
What will be the Size of the Vaccines Market during the forecast period?
Request Free Sample
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Vaccines Market 2019 - 2023
- Historic Market Size - Data Table on Global Vaccines Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.4 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- 5.5 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- 5.6 Disease Type segment analysis 2019 - 2023
- Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
- 5.7 Age Group segment analysis 2019 - 2023
- Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
- 5.8 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.9 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global Vaccines Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Subunit vaccines - Market size and forecast 2024-2029
- Chart on Subunit vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Subunit vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Subunit vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Subunit vaccines - Year-over-year growth 2024-2029 (%)
- 8.4 Live attenuated vaccines - Market size and forecast 2024-2029
- Chart on Live attenuated vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Live attenuated vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Live attenuated vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Live attenuated vaccines - Year-over-year growth 2024-2029 (%)
- 8.5 Inactivated vaccines - Market size and forecast 2024-2029
- Chart on Inactivated vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Inactivated vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Inactivated vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Inactivated vaccines - Year-over-year growth 2024-2029 (%)
- 8.6 Toxoid vaccines - Market size and forecast 2024-2029
- Chart on Toxoid vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Toxoid vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Toxoid vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Toxoid vaccines - Year-over-year growth 2024-2029 (%)
- 8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 9.4 Clinics - Market size and forecast 2024-2029
- Chart on Clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Clinics - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
- 10.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- 10.3 mRNA vaccines - Market size and forecast 2024-2029
- Chart on mRNA vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on mRNA vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on mRNA vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on mRNA vaccines - Year-over-year growth 2024-2029 (%)
- 10.4 Viral vector vaccines - Market size and forecast 2024-2029
- Chart on Viral vector vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Viral vector vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Viral vector vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Viral vector vaccines - Year-over-year growth 2024-2029 (%)
- 10.5 Protein based vaccines - Market size and forecast 2024-2029
- Chart on Protein based vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on Protein based vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on Protein based vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Protein based vaccines - Year-over-year growth 2024-2029 (%)
- 10.6 DNA vaccines - Market size and forecast 2024-2029
- Chart on DNA vaccines - Market size and forecast 2024-2029 ($ million)
- Data Table on DNA vaccines - Market size and forecast 2024-2029 ($ million)
- Chart on DNA vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on DNA vaccines - Year-over-year growth 2024-2029 (%)
- 10.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)
11 Market Segmentation by Route of Administration
- 11.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- 11.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 11.3 Intramuscular - Market size and forecast 2024-2029
- Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
- Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
- Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
- Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
- 11.4 Subcutaneous - Market size and forecast 2024-2029
- Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
- 11.5 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- 11.6 Intranasal - Market size and forecast 2024-2029
- Chart on Intranasal - Market size and forecast 2024-2029 ($ million)
- Data Table on Intranasal - Market size and forecast 2024-2029 ($ million)
- Chart on Intranasal - Year-over-year growth 2024-2029 (%)
- Data Table on Intranasal - Year-over-year growth 2024-2029 (%)
- 11.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 11.8 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
12 Market Segmentation by Disease Type
- 12.1 Market segments
- Chart on Disease Type - Market share 2024-2029 (%)
- Data Table on Disease Type - Market share 2024-2029 (%)
- 12.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- 12.3 Influenza - Market size and forecast 2024-2029
- Chart on Influenza - Market size and forecast 2024-2029 ($ million)
- Data Table on Influenza - Market size and forecast 2024-2029 ($ million)
- Chart on Influenza - Year-over-year growth 2024-2029 (%)
- Data Table on Influenza - Year-over-year growth 2024-2029 (%)
- 12.4 Human papillomavirus - Market size and forecast 2024-2029
- Chart on Human papillomavirus - Market size and forecast 2024-2029 ($ million)
- Data Table on Human papillomavirus - Market size and forecast 2024-2029 ($ million)
- Chart on Human papillomavirus - Year-over-year growth 2024-2029 (%)
- Data Table on Human papillomavirus - Year-over-year growth 2024-2029 (%)
- 12.5 Hepatitis - Market size and forecast 2024-2029
- Chart on Hepatitis - Market size and forecast 2024-2029 ($ million)
- Data Table on Hepatitis - Market size and forecast 2024-2029 ($ million)
- Chart on Hepatitis - Year-over-year growth 2024-2029 (%)
- Data Table on Hepatitis - Year-over-year growth 2024-2029 (%)
- 12.6 Measles, mumps, and rubella - Market size and forecast 2024-2029
- Chart on Measles, mumps, and rubella - Market size and forecast 2024-2029 ($ million)
- Data Table on Measles, mumps, and rubella - Market size and forecast 2024-2029 ($ million)
- Chart on Measles, mumps, and rubella - Year-over-year growth 2024-2029 (%)
- Data Table on Measles, mumps, and rubella - Year-over-year growth 2024-2029 (%)
- 12.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 12.8 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)
13 Market Segmentation by Age Group
- 13.1 Market segments
- Chart on Age Group - Market share 2024-2029 (%)
- Data Table on Age Group - Market share 2024-2029 (%)
- 13.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
- 13.3 Pediatric - Market size and forecast 2024-2029
- Chart on Pediatric - Market size and forecast 2024-2029 ($ million)
- Data Table on Pediatric - Market size and forecast 2024-2029 ($ million)
- Chart on Pediatric - Year-over-year growth 2024-2029 (%)
- Data Table on Pediatric - Year-over-year growth 2024-2029 (%)
- 13.4 Adult - Market size and forecast 2024-2029
- Chart on Adult - Market size and forecast 2024-2029 ($ million)
- Data Table on Adult - Market size and forecast 2024-2029 ($ million)
- Chart on Adult - Year-over-year growth 2024-2029 (%)
- Data Table on Adult - Year-over-year growth 2024-2029 (%)
- 13.5 Adolescent - Market size and forecast 2024-2029
- Chart on Adolescent - Market size and forecast 2024-2029 ($ million)
- Data Table on Adolescent - Market size and forecast 2024-2029 ($ million)
- Chart on Adolescent - Year-over-year growth 2024-2029 (%)
- Data Table on Adolescent - Year-over-year growth 2024-2029 (%)
- 13.6 Geriatric - Market size and forecast 2024-2029
- Chart on Geriatric - Market size and forecast 2024-2029 ($ million)
- Data Table on Geriatric - Market size and forecast 2024-2029 ($ million)
- Chart on Geriatric - Year-over-year growth 2024-2029 (%)
- Data Table on Geriatric - Year-over-year growth 2024-2029 (%)
- 13.7 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)
14 Customer Landscape
- 14.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
15 Geographic Landscape
- 15.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 15.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 15.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 15.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 15.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 15.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 15.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 15.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 15.9 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 15.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 15.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 15.12 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 15.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 15.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 15.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 15.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 15.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
16 Drivers, Challenges, and Opportunity/Restraints
- 16.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 16.4 Market opportunities/restraints
17 Competitive Landscape
- 17.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 17.3 Landscape disruption
- Overview on factors of disruption
- 17.4 Industry risks
- Impact of key risks on business
18 Competitive Analysis
- 18.2 Company ranking index
- 18.3 Market positioning of companies
- Matrix on companies position and classification
- 18.4 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
- 18.5 Bavarian Nordic AS
- Bavarian Nordic AS - Overview
- Bavarian Nordic AS - Product / Service
- Bavarian Nordic AS - Key offerings
- SWOT
- 18.6 Bharat Biotech Ltd.
- Bharat Biotech Ltd. - Overview
- Bharat Biotech Ltd. - Product / Service
- Bharat Biotech Ltd. - Key offerings
- SWOT
- 18.7 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- SWOT
- 18.8 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- SWOT
- 18.9 Dynavax Technologies Corp.
- Dynavax Technologies Corp. - Overview
- Dynavax Technologies Corp. - Product / Service
- Dynavax Technologies Corp. - Key offerings
- SWOT
- 18.10 Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Product / Service
- Emergent BioSolutions Inc. - Key offerings
- SWOT
- 18.11 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 18.12 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- 18.13 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 18.14 Moderna Inc.
- Moderna Inc. - Overview
- Moderna Inc. - Product / Service
- Moderna Inc. - Key offerings
- SWOT
- 18.15 Novavax Inc.
- Novavax Inc. - Overview
- Novavax Inc. - Product / Service
- Novavax Inc. - Key offerings
- SWOT
- 18.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 18.17 Sinovac Biotech Ltd.
- Sinovac Biotech Ltd. - Overview
- Sinovac Biotech Ltd. - Product / Service
- Sinovac Biotech Ltd. - Key offerings
- SWOT
19 Appendix
- 19.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 19.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 19.4 Research methodology
- 19.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 19.9 360 degree market analysis
- 360 degree market analysis
- 19.10 List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
